Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review)
暂无分享,去创建一个
[1] J. Milbrandt,et al. Mechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsions. , 2010, Biomaterials.
[2] Martin Holzer,et al. Single-walled carbon nanotubes activate platelets and accelerate thrombus formation in the microcirculation. , 2010, Toxicology.
[3] Jun Li,et al. Delivery and efficacy of a cancer drug as a function of the bond to the gold nanoparticle surface. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[4] M Ferrari,et al. Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[5] Matthew D. McDermott,et al. The hydrogel template method for fabrication of homogeneous nano/microparticles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[6] Phapanin Charoenphol,et al. Potential role of size and hemodynamics in the efficacy of vascular-targeted spherical drug carriers. , 2010, Biomaterials.
[7] Jianlin Shi,et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. , 2010, Biomaterials.
[8] J. Błasiak,et al. How to study dendriplexes II: Transfection and cytotoxicity. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[9] Robert Langer,et al. Spatiotemporal controlled delivery of nanoparticles to injured vasculature , 2010, Proceedings of the National Academy of Sciences.
[10] Yunhui Liu,et al. Diphtheria Toxin Mutant CRM197-Mediated Transcytosis across Blood–Brain Barrier In Vitro , 2010, Cellular and Molecular Neurobiology.
[11] Sei-Young Lee,et al. Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows , 2009, Nanotechnology.
[12] Chen Jiang,et al. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer. , 2009, Biomaterials.
[13] Jeffery Gaspard,et al. Polymerization of hydrogels inside self-assembled block copolymer vesicles. , 2009, Langmuir : the ACS journal of surfaces and colloids.
[14] Leaf Huang,et al. Nanoparticles evading the reticuloendothelial system: role of the supported bilayer. , 2009, Biochimica et biophysica acta.
[15] Ramanathan Vaidyanathan,et al. Antiangiogenic properties of silver nanoparticles. , 2009, Biomaterials.
[16] O. Eniola-Adefeso,et al. Fabrication of biodegradable spheroidal microparticles for drug delivery applications. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[17] Rekha Srinivasan,et al. In vitro and in vivo platelet targeting by cyclic RGD-modified liposomes. , 2009, Journal of biomedical materials research. Part A.
[18] R. Razavi,et al. Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[19] L. Traub. Tickets to ride: selecting cargo for clathrin-regulated internalization , 2009, Nature Reviews Molecular Cell Biology.
[20] Mauro Ferrari,et al. Design of bio-mimetic particles with enhanced vascular interaction. , 2009, Journal of biomechanics.
[21] D. Matei,et al. Pegylated liposomal doxorubicin in ovarian cancer , 2009, Therapeutics and clinical risk management.
[22] J. Maessen,et al. The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood. , 2009, Biomaterials.
[23] Vesa-Pekka Lehto,et al. In vivo delivery of a peptide, ghrelin antagonist, with mesoporous silicon microparticles. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[24] Yoshiro Kaneko,et al. Nitric oxide release in human aortic endothelial cells mediated by delivery of amphiphilic polysiloxane nanoparticles to caveolae. , 2009, Biomacromolecules.
[25] L. Jennings. Mechanisms of platelet activation: Need for new strategies to protect against platelet-mediated atherothrombosis , 2009, Thrombosis and Haemostasis.
[26] D. Begley,et al. Albumin nanoparticles targeted with Apo E enter the CNS by transcytosis and are delivered to neurones. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[27] Kristopher J. Koudelka,et al. Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection , 2009, Journal of Neuroimmunology.
[28] Erkki Ruoslahti,et al. Targeting atherosclerosis by using modular, multifunctional micelles , 2009, Proceedings of the National Academy of Sciences.
[29] C Jeffrey Brinker,et al. Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery. , 2009, Journal of the American Chemical Society.
[30] D. Discher,et al. Filamentous polymer nanocarriers of tunable stiffness that encapsulate the therapeutic enzyme catalase. , 2009, Biomacromolecules.
[31] J. Panyam,et al. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[32] Tanmay Bera,et al. Characterization of antiplatelet properties of silver nanoparticles. , 2009, ACS nano.
[33] Mauro Ferrari,et al. The association of silicon microparticles with endothelial cells in drug delivery to the vasculature. , 2009, Biomaterials.
[34] Gary Siuzdak,et al. Endothelial Targeting of Cowpea Mosaic Virus (CPMV) via Surface Vimentin , 2009, PLoS pathogens.
[35] Yu Xiao,et al. Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo. , 2009, Cancer biotherapy & radiopharmaceuticals.
[36] Eleonore Fröhlich,et al. The role of nanoparticle size in hemocompatibility. , 2009, Toxicology.
[37] Michael J Sailor,et al. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. , 2009, Nature materials.
[38] V. Wiwanitkit,et al. Gold nanoparticles and a microscopic view of platelets: a preliminary observation. , 2009, Cardiovascular journal of Africa.
[39] Kitae E. Park,et al. Target specific intracellular delivery of siRNA/PEI-HA complex by receptor mediated endocytosis. , 2009, Molecular pharmaceutics.
[40] Lisa Brannon-Peppas,et al. Active targeting schemes for nanoparticle systems in cancer therapeutics. , 2008, Advanced drug delivery reviews.
[41] Keishiro Tomoda,et al. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.
[42] Kenneth A. Dawson,et al. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.
[43] Stephanie E. A. Gratton,et al. The effect of particle design on cellular internalization pathways , 2008, Proceedings of the National Academy of Sciences.
[44] W. Freeman,et al. Porous silicon in drug delivery devices and materials. , 2008, Advanced drug delivery reviews.
[45] Mauro Ferrari,et al. The margination propensity of spherical particles for vascular targeting in the microcirculation , 2008, Journal of nanobiotechnology.
[46] Baowei Fei,et al. Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer. , 2008, Journal of the American Chemical Society.
[47] Riyi Shi,et al. Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death. , 2008, Nanomedicine.
[48] E. Simanek,et al. The role of the size and number of polyethylene glycol chains in the biodistribution and tumor localization of triazine dendrimers. , 2008, Molecular pharmaceutics.
[49] Samir Mitragotri,et al. Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[50] Eric Pridgen,et al. Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles , 2008, Molecular pharmaceutics.
[51] Samuel A Wickline,et al. Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery. , 2008, Biomaterials.
[52] H. Dai,et al. Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. , 2008, Journal of the American Chemical Society.
[53] Milan Makale,et al. Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis , 2008, Proceedings of the National Academy of Sciences.
[54] P. Buehler,et al. Structural stabilization in tetrameric or polymeric hemoglobin determines its interaction with endogenous antioxidant scavenger pathways. , 2008, Antioxidants & redox signaling.
[55] D. Wagner,et al. The vessel wall and its interactions. , 2008, Blood.
[56] Luisa Pedro,et al. Purification of Bionanoparticles , 2008, Chemical engineering & technology.
[57] M. Eid,et al. In vivo photodynamic activity of photosensitizer-loaded nanoparticles: formulation properties, administration parameters and biological issues involved in PDT outcome. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[58] A. Nemmar,et al. The Acute Proinflammatory and Prothrombotic Effects of Pulmonary Exposure to Rutile TiO2 Nanorods in Rats , 2008, Experimental biology and medicine.
[59] G. Bendas,et al. VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. , 2008, Biochimica et biophysica acta.
[60] Noriaki Ohuchi,et al. Presidential symposium : Individualized diagnosis for tailored treatment of breast cancer In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine , 2008 .
[61] Mauro Ferrari,et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.
[62] J. Salonen,et al. Mesoporous silicon in drug delivery applications. , 2008, Journal of pharmaceutical sciences.
[63] M. Ferrari,et al. Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI) , 2008 .
[64] N. M. Khazenzon,et al. Nanoconjugate based on polymalic acid for tumor targeting. , 2008, Chemico-biological interactions.
[65] Nastassja A. Lewinski,et al. Cytotoxicity of nanoparticles. , 2008, Small.
[66] Simon Benita,et al. Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. , 2008, Biomacromolecules.
[67] P. Hildgen,et al. Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability. , 2008, Molecular pharmaceutics.
[68] A. Paillard,et al. Influence of surface charge and inner composition of porous nanoparticles to cross blood-brain barrier in vitro. , 2007, International journal of pharmaceutics.
[69] J. Emmerich,et al. Magnetic control of vascular network formation with magnetically labeled endothelial progenitor cells. , 2007, Biomaterials.
[70] Ji Guo,et al. Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[71] Jie Xue,et al. Biomimetic glycoliposomes as nanocarriers for targeting P-selectin on activated platelets. , 2007, Bioconjugate chemistry.
[72] P. Swaan,et al. Endocytic mechanisms for targeted drug delivery. , 2007, Advanced drug delivery reviews.
[73] S. Mitragotri,et al. Making polymeric micro- and nanoparticles of complex shapes , 2007, Proceedings of the National Academy of Sciences.
[74] J. Lindner,et al. Molecular Imaging of Inflammation in Atherosclerosis With Targeted Ultrasound Detection of Vascular Cell Adhesion Molecule-1 , 2007, Circulation.
[75] James R Baker,et al. Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. , 2007, Small.
[76] M. Ferrari,et al. Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI) , 2007, Biomedical microdevices.
[77] G. Kenner,et al. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding. , 2007, Biochimica et biophysica acta.
[78] D. Discher,et al. Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.
[79] Norased Nasongkla,et al. Functionalized Micellar Systems for Cancer Targeted Drug Delivery , 2007, Pharmaceutical Research.
[80] Charles P. Lin,et al. Optical Imaging of the Adoptive Transfer of Human Endothelial Cells in Mice Using Anti-Human CD31 Monoclonal Antibody , 2007, Pharmaceutical Research.
[81] María J Alonso,et al. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). , 2007, Biomaterials.
[82] R. Jugdaohsingh,et al. Silicon and bone health. , 2007, The journal of nutrition, health & aging.
[83] A. Zimmer,et al. Apolipoprotein A-I coating of protamine-oligonucleotide nanoparticles increases particle uptake and transcytosis in an in vitro model of the blood-brain barrier. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[84] Sara Linse,et al. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles , 2007, Proceedings of the National Academy of Sciences.
[85] R. Eritja,et al. Water-soluble carbosilane dendrimers: synthesis biocompatibility and complexation with oligonucleotides; evaluation for medical applications. , 2007, Chemistry.
[86] S. Hsu,et al. Biocompatibility of poly(ether)urethane-gold nanocomposites. , 2006, Journal of biomedical materials research. Part A.
[87] W. Lu,et al. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. , 2006, Cancer research.
[88] P. Singh,et al. Virus-based nanoparticles (VNPs): platform technologies for diagnostic imaging. , 2006, Advanced drug delivery reviews.
[89] Raoul Kopelman,et al. Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors , 2006, Clinical Cancer Research.
[90] T. Dutta,et al. Investigations on the toxicological profile of functionalized fifth‐generation poly(propylene imine) dendrimer , 2006, The Journal of pharmacy and pharmacology.
[91] L. Wågberg,et al. The adsorption of hyperbranched polymers on silicon oxide surfaces. , 2006, Journal of colloid and interface science.
[92] R. Stan. Endocytosis pathways in endothelium: how many? , 2006, American journal of physiology. Lung cellular and molecular physiology.
[93] Samir Mitragotri,et al. Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[94] Wadih Arap,et al. Vascular Targeting: Recent Advances and Therapeutic Perspectives , 2006, Trends in Cardiovascular Medicine.
[95] Arezou A Ghazani,et al. Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. , 2006, Nano letters.
[96] M. Morandi,et al. Nanoparticle‐induced platelet aggregation and vascular thrombosis , 2005, British journal of pharmacology.
[97] D. Hammer,et al. I-domain of lymphocyte function-associated antigen-1 mediates rolling of polystyrene particles on ICAM-1 under flow. , 2005, Biophysical journal.
[98] M. Kirkham,et al. Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. , 2005, Biochimica et biophysica acta.
[99] K. Claffey,et al. Vascular endothelial growth factor selectively targets boronated dendrimers to tumor vasculature , 2005, Molecular Cancer Therapeutics.
[100] M. Conese,et al. Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[101] J. Oh,et al. Blood Compatibility of Cetyl Alcohol/Polysorbate-Based Nanoparticles , 2005, Pharmaceutical Research.
[102] M. Simionescu,et al. Immunoliposomes Directed Toward VCAM-1 Interact Specifically with Activated Endothelial Cells—A Potential Tool for Specific Drug Delivery , 2005, Pharmaceutical Research.
[103] Joseph M DeSimone,et al. Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. , 2005, Journal of the American Chemical Society.
[104] Mansoor Amiji,et al. Tumor-Targeted Gene Delivery Using Poly(Ethylene Glycol)-Modified Gelatin Nanoparticles: In Vitro and in Vivo Studies , 2005, Pharmaceutical Research.
[105] W. Lu,et al. Cationic albumin conjugated pegylated nanoparticle with its transcytosis ability and little toxicity against blood-brain barrier. , 2005, International journal of pharmaceutics.
[106] R. Langer,et al. Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis , 2005, The journal of gene medicine.
[107] D. Muruve,et al. The induction of inflammation by adenovirus vectors used for gene therapy. , 2005, Frontiers in bioscience : a journal and virtual library.
[108] H. El-Shall,et al. Interaction of PLGA nanoparticles with human blood constituents. , 2005, Colloids and surfaces. B, Biointerfaces.
[109] V. Muzykantov,et al. ICAM-1 recycling in endothelial cells: a novel pathway for sustained intracellular delivery and prolonged effects of drugs. , 2005, Blood.
[110] M. Markman,et al. Cardiac safety profile of prolonged (>or=6 cycles) pegylated liposomal doxorubicin administration in patients with gynecologic malignancies. , 2004, Gynecologic oncology.
[111] M. Bryszewska,et al. Influence of PAMAM dendrimers on human red blood cells. , 2004, Bioelectrochemistry.
[112] Shmuel Einav,et al. Dynamics of Blood Flow and Platelet Transport in Pathological Vessels , 2004, Annals of the New York Academy of Sciences.
[113] C James Kirkpatrick,et al. Effects of nano-scaled particles on endothelial cell function in vitro: Studies on viability, proliferation and inflammation , 2004, Journal of materials science. Materials in medicine.
[114] Aliasger K Salem,et al. Leukocyte-inspired biodegradable particles that selectively and avidly adhere to inflamed endothelium in vitro and in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[115] F. Szoka,et al. Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes* , 2003, Journal of Biological Chemistry.
[116] F. Bates,et al. Polymer vesicles in vivo: correlations with PEG molecular weight. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[117] G. Nash,et al. Rheological properties of the blood influencing selectin-mediated adhesion of flowing leukocytes. , 2003, American journal of physiology. Heart and circulatory physiology.
[118] E. Namork,et al. HUVEC take up opsonized zymosan particles and secrete cytokines IL-6 and IL-8 in vitro. , 2003, FEMS immunology and medical microbiology.
[119] Rakesh K Jain,et al. Red blood cells augment leukocyte rolling in a virtual blood vessel. , 2002, Biophysical journal.
[120] A. Hoffman,et al. A biomimetic pH-responsive polymer directs endosomal release and intracellular delivery of an endocytosed antibody complex. , 2002, Bioconjugate chemistry.
[121] D. Hammer,et al. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes. , 2002, Biomaterials.
[122] A. Hoffman,et al. pH-sensitive polymers that enhance intracellular drug delivery in vivo. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[123] Peter Ramge,et al. Apolipoprotein-mediated Transport of Nanoparticle-bound Drugs Across the Blood-Brain Barrier , 2002, Journal of drug targeting.
[124] G. Molema,et al. Vascular Endothelium in Inflamed Tissue as a Target for Site Selective Delivery of Drugs , 2001 .
[125] G. Hoffman,et al. Inflammatory Diseases of Blood Vessels , 2001 .
[126] David M. Brown,et al. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. , 2001, Toxicology and applied pharmacology.
[127] D Guthrie,et al. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[128] V. Muzykantov. Targeting of superoxide dismutase and catalase to vascular endothelium. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[129] R. Löbenberg,et al. Interaction of Poly(butylcyanoacrylate) Nanoparticles with the Blood-Brain Barrier in vivo and in vitro , 2001, Journal of drug targeting.
[130] M J Pearson,et al. Influence of erythrocyte aggregation on leukocyte margination in postcapillary venules of rat mesentery. , 2000, American journal of physiology. Heart and circulatory physiology.
[131] G. Garcı́a-Cardeña,et al. Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesis a , 2000, Annals of the New York Academy of Sciences.
[132] D. Putnam,et al. Design of imidazole-containing endosomolytic biopolymers for gene delivery. , 2000, Biotechnology and bioengineering.
[133] L. Fenart,et al. Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier. , 1999, The Journal of pharmacology and experimental therapeutics.
[134] D. Hammer,et al. Polymersomes: tough vesicles made from diblock copolymers. , 1999, Science.
[135] D. McPherson,et al. In vivo targeting of acoustically reflective liposomes for intravascular and transvascular ultrasonic enhancement. , 1999, Journal of the American College of Cardiology.
[136] R K Jain,et al. Role of erythrocytes in leukocyte-endothelial interactions: mathematical model and experimental validation. , 1996, Biophysical journal.
[137] R K Jain,et al. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.
[138] D. Scherman,et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[139] Y. Ohtsuka,et al. Platelet aggregation induced by latex particles. I. Effects of size, surface potential and hydrophobicity of particles. , 1989, Biomaterials.
[140] R M Heethaar,et al. Blood platelets are concentrated near the wall and red blood cells, in the center in flowing blood. , 1988, Arteriosclerosis.
[141] F. Millero,et al. Conditions for the occurrence of large near-wall excesses of small particles during blood flow. , 1988, Microvascular research.
[142] H. Movat,et al. PLATELET PHAGOCYTOSIS AND AGGREGATION , 1965, The Journal of cell biology.
[143] J. Lahann,et al. Multicompartmental microcylinders. , 2009, Angewandte Chemie.
[144] Mauro Ferrari,et al. Intravascular Delivery of Particulate Systems: Does Geometry Really Matter? , 2008, Pharmaceutical Research.
[145] Na Zhang,et al. PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1. , 2008, Bioconjugate chemistry.
[146] V. Muzykantov,et al. Targeted delivery of therapeutics to endothelium , 2008, Cell and Tissue Research.
[147] Yun Chen,et al. Tumor-targeted delivery of siRNA by self-assembled nanoparticles. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.
[148] V. Muzykantov,et al. Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapies. , 2008, Biomaterials.
[149] P. Bagchi,et al. Hydrodynamic interaction between erythrocytes and leukocytes affects rheology of blood in microvessels. , 2007, Biorheology.
[150] R. Schwendener. Liposomes in biology and medicine. , 2007, Advances in experimental medicine and biology.
[151] Seungpyo Hong,et al. The Binding Avidity of a Nanoparticle-based Multivalent Targeted Drug Delivery Platform , 2022 .
[152] Hong-Zhuan Chen,et al. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[153] B. Pogue,et al. Vascular and cellular targeting for photodynamic therapy. , 2006, Critical reviews in eukaryotic gene expression.
[154] Shelton D Caruthers,et al. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[155] J. Fréchet,et al. Dendrimers and dendritic polymers in drug delivery. , 2005, Drug discovery today.
[156] I. Zuhorn,et al. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.
[157] P. Seth,et al. The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid. , 2002, Human gene therapy.
[158] G. Ginsburg,et al. Atherosclerosis and cancer: common molecular pathways of disease development and progression. , 2001, Annals of the New York Academy of Sciences.
[159] C Baquey,et al. In vitro study of the hemocompatibility of superparamagnetic contrast agent for magnetic resonance imaging. , 1994, Clinical materials.